August 27, 2018
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

Dr. Hudson appointed to PCORI advisory panel Read more.
The NRG Oncology publications page on the website has moved. Read more

AMENDMENTS
BRAIN
NRG-BN003:  Amendment 1; version date June 22, 2018 (posted to CTSU). Please contact the CTSU Help Desk for tracked protocol documents.

RTOG 1114: Amendment 8; version date August 7, 2018 (posted to NRG)

BREAST
NRG-BR002:  Amendments 4 and 5; version dates June 14, 2018, and July 11, 2018 (posted to CTSU). Please contact the CTSU Help Desk for tracked protocol documents.

OTHER PROTOCOL NOTICES
1. BRAIN
NRG-BN003: A patient brochure is available on the CTSU website.

2. BREAST
NRG-BR003: Workshop Slides from the NRG Oncology Meeting (posted to CTSU)

3. COLORECTAL

NRG-GI002: Memo regarding the IND number for MK-3475 (Pembrolizumab) (posted to CTSU)

4. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for September 12, 2018.

 

 

DRUG SAFETY UPDATES AND INVESTIGTOR’S BROCHURE NOTICE
Safety updates and an Investigator’s Brochure notice have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR
SAFETY REPORTS

IB NOTICE

Apalutamide

NRG-GU006

CTSU

X**

Ipilimumab

NRG-BN002

NRG-GY003

NRG

NRG

 

Nivolumab

 

NRG-BN002

NRG-GY002

NRG-GY003

NRG

NRG

NRG

 

 ** The apalutamide IB can be obtained from the CTSU by completing the CTSU Request for Clinical Brochure form. This form can be found on the CTSU website under documents > site registration.

 

DR. HUDSON APPOINTED TO NATIONAL RESEARCH INSTITUTE’S ADVISORY PANEL
Matthew F. Hudson, PhD, MPH, NRG Oncology Cancer Care Delivery Research (CCDR) Vice Chair, has been appointed by the Patient-Centered Outcomes Research Institute (PCORI) as a member of its Advisory Panel on Patient Engagement. Read more.

LABOR DAY HOLIDAY CLOSURES
The NRG Oncology Operations Offices, Statistics and Data Management Centers (SDMCs), Biospecimen Banks, Serum Bank, and McKesson's Clinical Research Services will be closed on Monday, September 3, 2018 in observance of Labor Day. Please note some offices will close early on Friday, August 31. For more information, please see the memorandum posted on CTSU and the NRG Oncology website.

CTEP Action Letter – Posting Process Update
As of August 27, 2018, CTEP-issued Action Letters will be posted to the Supplemental Documents tab of the CTSU website by the coordinating groups. The CIRB will no longer post the Action Letter with its review. This change allows for immediate distribution of the Action Letter by the coordinating Group. The CIRB will continue to process and review all Action Letters according to its SOPs.  An Acknowledgement of Receipt and a determination of whether the event constitutes an Unanticipated Problem will be issued and posted by the CIRB to the CIRB Documents tab. Please refer to the CIRB Document Posting Quickguide for more information regarding which documents are posted to the CIRB Documents tab. Please contact the CIRB Helpdesk at NCICIRBContact@emmes.com or at 1-888-657-3711 if you have any additional questions or comments. 

NEW LOCATION ON WEBSITE
Please note that the NRG Oncology Publications tab on the website has relocated. You can now find the publications section under the Clinical Trials tab of the website:  nrgoncology.org/Clinical-Trials/Publications 

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES
Seider MJ, Pugh SL, Langer C, Wyatt G, Demas W, Rashtian A, Clausen CL, Derdel JD, Cleary SF, Peters CA, Ramalingam A, Clarkson JE, Tomblyn M, Rabinovitch RA, Kachnic LA, Berk LB; NRG Oncology. Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial. Ann Nucl Med. 2018 Aug 9. doi: 10.1007/s12149-018-1278-4. [Epub ahead of print] PubMed PMID: 30094545. Read more

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings
ASCO Research Community Forum Annual Meeting; Sep 23-24, 2018; Washington, DC

American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Antonio, TX

College of American Pathologists (CAP); Oct 20-24, 2018, Chicago, IL

European Society for Medical Oncology (ESMO); Oct 19-23, 2018; Munich, Germany

International Gynecologic Cancer Society (IGCS); Biennial; Sep 14-16, 2018; Kyoto, Japan

PA Breast Cancer Coalition (PBCC); October 19, 2018; Harrisburg, PA

Society of Clinical Research (SOCRA); Sep 28-30, 2018; New Orleans, LA

Upcoming Abstract Submission Deadlines
American Society of Clinical Oncology (ASCO) GI; Jan 17-19, 2019; San Francisco, CA; due to publications committee Sep 12, 2018; meeting abstracts submission deadline Sep 26, 2018

American Society of Clinical Oncology (ASCO) GU; Feb 14-16, 2019; San Francisco, CA; due to publications committee Oct 9, 2018; meeting abstracts submission deadline Oct 23, 2018

European Society for Medical Oncology (ESMO); Oct 19-23, 2018;Munich, Germany; Late-breaking Sep 17, 2018

European Society for Radiotherapy and Oncology (ESTRO); Apr 26-30, 2019; Milan, Italy; due to publications committee Oct 8, 2018; meeting abstracts submission deadline Oct 22, 2018

NRG Oncology is proud to be an active participant of #CancerMoonShot.
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse